Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Descriptive, Retrospective, Single-Arm Cohort Study on the Use of Selective Internal Radiation Therapy (SIRT) with Yttrium-90 Microspheres for Unresectable Primary Hepatocellular Carcinoma (HCC) in the Chinese Population

NCT06712017 is registered in ClinicalTrials.gov with GrandPharma (China) Co., Ltd. as lead sponsor.

NCT NCT06712017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06712017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Descriptive, Retrospective, Single-Arm Cohort Study on the Use of Selective Internal Radiation Therapy (SIRT) with Yttrium-90 Microspheres for Unresectable Primary Hepatocellular Carcinoma (HCC) in the Chinese Population
Lead sponsor
GrandPharma (China) Co., Ltd.
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 22, 2024
Completion date
June 30, 2025
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc), hepatocellular carcinoma non-resectable